Table 4.
Outcome | No. of studies | No. of participants | Estimated effect (as SMD) | Certainty of evidence (GRADE) |
---|---|---|---|---|
Fat-free mass | 8 | 418 | 0.48 | ⨁⨁⨁◯ moderated |
Tendon morphology | 4 | 114 | 0.67 | ⨁◯◯◯ very lowb,c,d |
Tendon mechanical properties | 4 | 111 | 0.05 | ⨁◯◯◯ very lowa,c,d,e |
Muscle architecture | 5 | 161 | 0.39 | ⨁⨁◯◯ lowc,d |
Maximal strength | 11 | 511 | 0.19 | ⨁⨁◯◯ lowc,d |
Recovery maximal strength post | 3 | 98 | 0.15 | ⨁⨁◯◯ lowc,d |
Recovery maximal strength 24 h | 4 | 113 | 0.26 | ⨁⨁◯◯ lowc,d |
Recovery maximal strength 48 h | 4 | 113 | 0.31 | ⨁⨁◯◯ lowc,d |
Recovery reactive strength 24 h | 3 | 91 | 0.41 | ⨁⨁◯◯ lowc,d |
Recovery reactive strength 48 h | 3 | 91 | 0.43 | ⨁⨁◯◯ lowc,d |
Recovery muscle soreness post | 4 | 121 | − 0.21 | ⨁⨁◯◯ lowc,d |
Recovery muscle soreness 24 h | 4 | 127 | − 0.05 | ⨁⨁◯◯ lowc,d |
Recovery muscle soreness 48 h | 5 | 135 | 0.09 | ⨁⨁◯◯ lowc,d |
Reasons for downgrades: a = risk of bias, b = inconsistency/heterogeneity, c = participants and/or interventions differed (training history, duration, study design), d = imprecision/ wide confidence intervals, e = publication bias (detected via Egger’s test)
SMD standardized mean difference